Thrombocytopenia in neonates: causes and outcomes
暂无分享,去创建一个
A. Kumral | N. Duman | H. Ören | G. Irken | Ö. Tüfekçi | Ezgi Ulusoy
[1] R. Christensen,et al. Thrombocytosis and thrombocytopenia in the NICU: incidence, mechanisms and treatments , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[2] H. Sallmon,et al. Clinical and research issues in neonatal anemia and thrombocytopenia , 2012, Current opinion in pediatrics.
[3] J. Khoury,et al. Characterizing maternal glycemic control: a more informative approach using semiparametric regression , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[4] I. Roberts,et al. How I manage neonatal thrombocytopenia , 2012, British journal of haematology.
[5] A. Kent,et al. Mortality and Adverse Neurologic Outcomes Are Greater in Preterm Male Infants , 2012, Pediatrics.
[6] S. Holzhauer,et al. Diagnosis and management of neonatal thrombocytopenia. , 2011, Seminars in fetal & neonatal medicine.
[7] Jodi Beachy. Neonatal Alloimmune Thrombocytopenia: A Case Study , 2011, Neonatal Network.
[8] R. Christensen. Platelet Transfusion in the Neonatal Intensive Care Unit: Benefits, Risks, Alternatives , 2011, Neonatology.
[9] F. Walther,et al. Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study , 2011, BMC pediatrics.
[10] P. Clarke,et al. Prospective, Observational Study of Outcomes in Neonates With Severe Thrombocytopenia , 2009, Pediatrics.
[11] H. Sallmon,et al. New insights into the mechanisms of nonimmune thrombocytopenia in neonates. , 2009, Seminars in perinatology.
[12] M. Kroh,et al. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus. , 2009, Journal of pediatric surgery.
[13] Y. Ramesh Bhat,et al. Neonatal thrombocytopenia associated with maternal pregnancy induced hypertension , 2008, Indian journal of pediatrics.
[14] M. Saxonhouse,et al. Neonatal thrombocytopenia: what we do and don't know. , 2008, Early Human Development.
[15] K. Sekar,et al. Treatment of patent ductus arteriosus: indomethacin or ibuprofen? , 2008, Journal of Perinatology.
[16] R. Christensen,et al. Do platelet transfusions in the NICU adversely affect survival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system , 2007, Journal of Perinatology.
[17] S. Ogawa,et al. In Vivo Effects of Notch Signaling Inhibitor on Tumor Growth and Its Mechanism of Action. , 2006 .
[18] A. Casbard,et al. A multi-centre prospective observational study of platelet transfusion practice in neonates with severe thrombocytopenia. , 2006 .
[19] T. Kiehn,et al. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system , 2006, Journal of Perinatology.
[20] I. Roberts,et al. Neonatal thrombocytopenia. , 2005, Early human development.
[21] I. Roberts,et al. Neonatal thrombocytopenia: causes and management , 2003, Archives of disease in childhood. Fetal and neonatal edition.
[22] D. Cooney,et al. Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. , 2003, Journal of pediatric surgery.
[23] L. Rimsza,et al. Mechanisms underlying thrombocytopenia in the neonatal intensive care unit , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[24] E. Letsky,et al. Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients , 2002, Transfusion medicine.
[25] D. Theriaque,et al. Epidemiologic and Outcome Studies of Patients Who Received Platelet Transfusions in the Neonatal Intensive Care Unit , 2001, Journal of Perinatology.
[26] D. Theriaque,et al. Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions , 2001, Transfusion.
[27] M. Uhrynowska,et al. Neonatal and maternal thrombocytopenia: incidence and immune background , 2000, European journal of haematology.
[28] I. Roberts,et al. Haematological abnormalities in the growth-restricted infant , 1999 .
[29] I. Durand-zaleski,et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. , 1997, Blood.
[30] I. Roberts,et al. Circulating Megakaryocytes and Their Progenitors in Early Thrombocytopenia in Preterm Neonates , 1996, Pediatric Research.
[31] A. Homans. Thrombocytopenia in the neonate. , 1996, Pediatric clinics of North America.
[32] N. Olgun,et al. Assessment of clinical impact and predisposing factors for neonatal thrombocytopenia , 1994, Indian journal of pediatrics.
[33] S. Jain. Ibuprofen-induced thrombocytopenia. , 1994, The British journal of clinical practice.
[34] T. Gomella. Neonatology: Management, Procedures, On-Call Problems, Diseases, Drugs , 1992 .
[35] J. Kelton,et al. Frequency and mechanism of neonatal thrombocytopenia. , 1986, The Journal of pediatrics.
[36] L Neumann,et al. Thrombocytopenia in the high-risk infant. , 1980, The Journal of pediatrics.